Taysha Gene Therapies, Inc. · NASDAQ:TSHA
BlackRock, Inc. reported a 6.50% stake in Taysha Gene Therapies, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 21, 2026
BlackRock, Inc. reported a 6.50% stake in Taysha Gene Therapies, Inc., 17,852,291 shares, as a passive investor on Dec 31, 2025. Filed Jan 21, 2026 (Schedule 13G/A).
- Stake
- 6.50%
- Shares
- 17,852,291
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.50% | 17,852,291 |
Source
Related
- Taysha Gene Therapies, Inc.
- BlackRock, Inc.
- Taysha Gene Therapies, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 16, 2025
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Morgan Stanley · Aug 13, 2026
- Form 4 · Nagendran Sukumar · Jul 10, 2026
- Form 4 · Stalfort John A III · Jun 2, 2026
- Form 4 · Donenberg Phillip B. · Jun 2, 2026